Mr. Alon Bloomenfeld is CEO and founder of Raziel Therapeutics. He served in management positions and as a board member for many public and private companies in healthcare, the high-tech industry. Prior to founding Raziel, Mr. Bloomenfeld served as the CFO of Collplant (NASDAQ: CLGN), Biomedix Incubator Ltd. (TASE:BMDX), and BrightCom Technologies.